Aggregator

FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results

1 month 3 weeks ago

Companies and researchers often fail to disclose negative trial results, resulting in significant gaps in the public record and a publication bias that obscures the true landscape of drug development outcomes—overrepresenting successes and underrepresenting failures. This gap can also create a distorted perception of the safety and efficacy of medical products.

The post FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results appeared first on MedTech Intelligence.

Rich West